{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-037086","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2022-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.190406+00:00","generated_at":"2026-06-26T19:32:51.805674+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kiora Pharmaceuticals' Corporate Controller resigns; CEO appointed as interim principal financial officer","bullets":["Michael Meluzio resigned as Corporate Controller and interim principal financial/accounting officer on March 18, 2022.","Brian M. Strem, Ph.D., President and CEO, appointed as principal financial and accounting officer effective March 18, 2022.","Company engaged Danforth Advisors, LLC for interim finance and accounting services until a permanent replacement is found.","Resignation not due to any disagreement with company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-037086","json":"https://secwatch.observer/filing/0001104659-22-037086.json","markdown":"https://secwatch.observer/filing/0001104659-22-037086.md","text":"https://secwatch.observer/filing/0001104659-22-037086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922037086/0001104659-22-037086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922037086/tm2210197d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T19:32:51.805674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"279e073d3b","claim":"Brian M. Strem was appointed as President and Chief Executive Officer at KIORA PHARMACEUTICALS INC.","evidence_excerpt":"Effective as of March 18, 2022, Brian M. Strem, Ph.D., the Company’s President and Chief Executive Officer, was appointed as the Company’s principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922037086/0001104659-22-037086-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b66ca1d69d","claim":"Michael Meluzio resigned as Corporate Controller at KIORA PHARMACEUTICALS INC.","evidence_excerpt":"On March 18, 2022, Michael Meluzio resigned as the Corporate Controller of Kiora Pharmaceuticals, Inc. (the “Company”) to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922037086/0001104659-22-037086-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Corporate Controller"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}